Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Multidrug-resistant tuberculosis]

E Bouvet1

  • 1Service des Maladies infectieuses, Hôpital Bichat-Claude Bernard, Paris.

Presse Medicale (Paris, France : 1983)
|March 2, 1996
PubMed
Summary
This summary is machine-generated.

Multiresistant tuberculosis is rare in France, with a 0.7% resistance rate. Surveillance and strict patient isolation are key to managing this serious infectious disease.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Determinants of sustainable adoption in primary care of a clinical decision support system for antimicrobial prescribing: A qualitative study.

Infectious diseases now·2025
Same author

Maternity staff immunization coverage against pertussis and maternal vaccination practices: Results of a 2017 cross-sectional survey in five public maternity hospitals.

Medecine et maladies infectieuses·2019
Same author

Long-term plasma pharmacokinetics of bedaquiline for multidrug- and extensively drug-resistant tuberculosis.

The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease·2019
Same author

Score for pulmonary tuberculosis in patients with clinical presumption of tuberculosis in a low-prevalence area.

The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease·2018
Same author

In reply to 'Delay in tuberculosis diagnosis and treatment: what about smear and mycobacteriological status?' [Correspondence].

The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease·2017
Same author

Use of fluoroquinolones for the treatment of TB: 8 years of experience.

The Journal of antimicrobial chemotherapy·2015
Same journal

Predictive analytics and risk stratification models in internal medicine: from risk scores to real-time machine learning.

Presse medicale (Paris, France : 1983)·2026
Same journal

Artificial Intelligence in skin disease therapeutics: from drug discovery to personalized treatment pathways.

Presse medicale (Paris, France : 1983)·2026
Same journal

AI in clinical diagnostics in dermatology: applications, validation, and real-world use cases.

Presse medicale (Paris, France : 1983)·2026
Same journal

Artificial Intelligence in medical research and publishing: progress, risks, and future perspectives.

Presse medicale (Paris, France : 1983)·2026
Same journal

Ethical, legal, and regulatory challenges in AI-based healthcare tools.

Presse medicale (Paris, France : 1983)·2026
Same journal

Decision-making for clinicians.

Presse medicale (Paris, France : 1983)·2026
See all related articles

Area of Science:

  • Infectious Diseases
  • Microbiology
  • Public Health

Context:

  • The quality of tuberculosis diagnosis and treatment influences the prevalence of multidrug-resistant strains.
  • The United States experienced a surge in multidrug-resistant tuberculosis (MDR-TB) in 1991, particularly in patients with acquired immune deficiency syndrome (AIDS), prompting global health interventions.
  • France currently reports a low incidence of MDR-TB.

Purpose:

  • To report the current prevalence of multidrug-resistant tuberculosis in France.
  • To analyze factors associated with multidrug-resistant tuberculosis in France, including primary and secondary resistance.
  • To highlight the importance of continuous surveillance and management strategies for multidrug-resistant tuberculosis.

Summary:

Related Experiment Videos

  • Continuous surveillance by 33 University Hospitals in Paris and 300 bacteriology laboratories across France indicates a 0.7% rate of multidrug resistance.
  • From 1992 to 1994 in Paris, six of eight primary multidrug-resistant tuberculosis cases were linked to human immunodeficiency virus (HIV) infection.
  • Approximately 50% of secondary multidrug-resistant tuberculosis cases involved individuals born outside France.

    • Impact:

    • Effective surveillance systems are crucial for monitoring and controlling the spread of multidrug-resistant tuberculosis.
    • Management of multidrug-resistant tuberculosis requires strict isolation protocols and specialized treatment regimens involving toxic antibiotics.
    • Understanding the epidemiology of multidrug-resistant tuberculosis, including risk factors and patient demographics, is essential for public health policy and clinical practice.